Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS-8080 vs Physician's Choice in Advanced Breast Cancer
NCT07024173Phase 3Recruiting
- Sponsor
- Shandong Suncadia Medicine Co., Ltd.
- Start
- Jul 2025
- Primary completion
- Aug 2027
- Modality
- Molecular Glues
- Countries
- 1
01
Overview
A Phase 3 trial of HRS-8080 in breast cancer, sponsored by Shandong Suncadia Medicine Co., Ltd.. Started Jul 2025; status: recruiting.
02
Drugs
HRS-8080
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT07024173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07024173.